S. F. Leung - Concepedia

Author

S. F. Leung

Chinese University of Hong Kong

Also Known As

S F LEUNG, S F Leung, S Leung, S. F. LEUNG, S. F. Leung, S. Leung, S.-F. Leung, S.F. LEUNG, S.F. Leung, SF LEUNG

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

Chinese University of Hong Kong Prince of Wales Hospital

About

S. F. Leung is an author at Chinese University of Hong Kong specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	25	3.4K
2	Health Sciences	13	13	1.1K
3	Engineering	1	1	11
4	Public Health	1	1	75
5	Social Sciences	1	1	48

S. F. Leung

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Y M Lo, Lisa Chan, Kwok Wai Lo, PubMed ImmunologyPathologyCancer RegistrationNasopharyngeal CarcinomaPlasma Ebv Dna	1999	774
Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience Anne W.M. Lee, W.M. Sze, Joseph S. K. Au, International Journal of Radiation OncologyBiologyPhysics MedicineNasopharyngeal CancerPathologyHong Kong ExperienceNasopharyngeal Carcinoma	2005	584
Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma Anthony T.�C. Chan, S. F. Leung, Roger KC Ngan, JNCI Journal of the National Cancer Institute	2005	516
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan, Journal of Clinical Oncology	2002	482
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Y. M. Dennis Lo, Lisa Chan, Anthony T.�C. Chan, PubMed Tumor BiologySerum Ebv DnaCancer DetectionTemporal CorrelationTumor Recurrence	1999	397
Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Yuk Ming Dennis Lo, S. F. Leung, Lisa Chan, PubMed Tumor BiologyRadiation MedicineRadiation TherapyMedicineImmunology	2000	221
Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma Peter M. L. Teo, W. H. Kwan, W. Y. Lee, Cancer	1996	217
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography P. Teo, Peter S. Y. Yu, W. Y. Lee, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNondisseminated Nasopharyngeal CarcinomaHealth SciencesRadiation TherapyMedical Imaging	1996	214
Plasma Epstein–Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma S. F. Leung, K.C. Allen Chan, Brigette Ma, Annals of Oncology Cancer-associated VirusRadiation TherapyMedicineNasopharyngeal CancerRadiotherapy Course	2014	210
Phase II Study of Neoadjuvant Carboplatin and Paclitaxel Followed by Radiotherapy and Concurrent Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: Therapeutic Monitoring With Plasma Epstein-Barr Virus DNA Anthony T.�C. Chan, Yuk Ming Dennis Lo, S. F. Leung, Journal of Clinical Oncology	2004	135

Page 1